Chan Henry Lee Sells 1,202 Shares of Beigene, Ltd. (NASDAQ:ONC) Stock

Beigene, Ltd. (NASDAQ:ONCGet Free Report) SVP Chan Henry Lee sold 1,202 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $258.04, for a total value of $310,164.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Beigene Stock Performance

NASDAQ ONC opened at $259.00 on Thursday. The firm has a market cap of $25.35 billion, a P/E ratio of -31.43, a price-to-earnings-growth ratio of 7.73 and a beta of 0.63. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.93 and a quick ratio of 1.72. Beigene, Ltd. has a 1 year low of $126.97 and a 1 year high of $268.45.

About Beigene

(Get Free Report)

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.

Featured Stories

Receive News & Ratings for Beigene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beigene and related companies with MarketBeat.com's FREE daily email newsletter.